CD44 and breast cancer: Grosse-Wilde A et al. evaluated the stemness of the hybrid epithelial-mesenchymal state of breast cancer cells and reported that CD24+/CD44- are more expressed in epithelial phenotype and CD24-/CD44+ in mesenchymal phenotypes [28].